Although increased levels of the soluble receptor for IL-33, sST2, is a marker of poor prognosis in patients with heart failure and myocardial infarction [21], the prognostic value of circulating IL-33 in cardiovascular disease was not studied extensively. This evidence concerns the gene IL33 and cardiovascular disorder.